Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |